Clinical Trials Sponsored by Genentech, Inc; Onyx Therapeutics, Inc.
Total 4477 results
-
AbbVieGenentech, Inc; Onyx Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States, Australia, Hungary, Puerto Rico, Spain
-
BayerOnyx Therapeutics, Inc.Completed
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
BayerOnyx Therapeutics, Inc.CompletedBreast CancerSpain, Ireland, Japan, Russian Federation, United States, Australia, Austria, Czechia, Belgium, China, Germany, Hungary, Israel, South Africa, United Kingdom, France, Greece, Puerto Rico, Italy, Canada, Poland, Sweden, Argentina
-
Yale UniversityOnyx Therapeutics, Inc.Completed
-
Emory UniversityOnyx Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
University of ArkansasOnyx Therapeutics, Inc.No longer available
-
University Hospital, ToulouseCelgene; Onyx Therapeutics, Inc.UnknownMultiple MyelomaFrance
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.TerminatedLymphomaUnited States
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.Completed
-
Celldex TherapeuticsGenentech, Inc.TerminatedMelanoma | Neoplasms | Neoplasms by Histologic Type | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Head and Neck Cancer | Bladder Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Case Comprehensive Cancer CenterBayer; Onyx Therapeutics, Inc.TerminatedCarcinoma, HepatocellularUnited States
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Poseida Therapeutics, Inc.Roche-GenentechRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)United States
-
G1 Therapeutics, Inc.Roche-GenentechTerminatedSmall Cell Lung CancerUnited States, Spain, France, Bulgaria, Ukraine, Estonia, Latvia
-
M.D. Anderson Cancer CenterBayer; Celgene; Onyx Therapeutics, Inc.Completed
-
Poseida Therapeutics, Inc.Roche-GenentechRecruitingMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
University of WashingtonGenentech, Inc.; Oncotelic Therapeutics, Inc.WithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Genentech, Inc.Not yet recruitingSolid Tumor, Adult | Refractory Cancer | Recurrent Cancer
-
Genentech, Inc.Recruiting
-
Genentech, Inc.Recruiting
-
Genentech, Inc.RecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Australia, Israel
-
Genentech, Inc.RecruitingChronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisUnited States, Australia, United Kingdom, Canada
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
Genentech, Inc.RecruitingDiabetic Macular EdemaUnited States, Puerto Rico, Kenya, India
-
Genentech, Inc.RecruitingChronic Obstructive Pulmonary DiseaseUnited States, Australia, United Kingdom, Belgium, Israel, Korea, Republic of, Spain, France, Denmark, Argentina, New Zealand, South Africa, Peru, Chile, Canada, Germany, Mexico, Netherlands, Sweden, Hong Kong, Bulgaria, Czechia, Au... and more
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid TumorsUnited States, Korea, Republic of, Spain, United Kingdom, Brazil, Israel, New Zealand, Netherlands, Canada, Australia, Switzerland, Belgium, Italy, Norway, Poland, Hungary, Kenya, Russian Federation, Germany
-
Genentech, Inc.RecruitingSolid TumorsKorea, Republic of, Netherlands, Spain, United States, Canada, Italy, Australia, Belgium, Brazil
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Genentech, Inc.TerminatedCrohn's Disease | Ulcerative ColitisGermany, Italy, Poland, Russian Federation, Serbia, United States, Ukraine, Bulgaria, Georgia, Greece, Ireland, Moldova, Republic of, Spain, United Kingdom
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
Genentech, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States
-
Genentech, Inc.CompletedLymphoma, Non HodgkinUnited States, France
-
Genentech, Inc.CompletedHealthy VolunteersUnited Kingdom
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma | Solid CancersUnited States, Spain, France, Canada
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedHealthy VolunteersUnited States
-
Genentech, Inc.Terminated
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States